Abstract

Objective: Individuals with avoidant/restrictive food intake disorder (ARFID) commonly endorse lacking interest in eating/food, difficulties recognizing hunger, and early satiation. Cholecystokinin (CCK) and ghrelin may be important biologic mechanisms in ARFID given their role in appetite signaling. We investigated whether youth with ARFID-lack of interest had greater CCK and lower ghrelin levels compared to youth without this presentation across timepoints and whether greater reductions in CCK and increases in ghrelin were associated with ARFID symptom improvement over a two-year period.

Methods: One hundred youth (49% female, mean [SD] age=15.87 [3.89] years, mean [SD] body mass index percentile=37.71 [35.16]) recruited from a single-center clinic and surrounding community, initially meeting DSM-5 criteria for full/subthreshold ARFID completed the Pica, ARFID, and Rumination Disorder Interview at baseline and follow-up over two years (July 2016–September 2022) to determine ARFID diagnosis, presentation type, and severity scores. We obtained fasting plasma levels of CCK and ghrelin at each timepoint.

Results: Youth with ARFID-lack of interest had higher CCK than those without this presentation, though there were no differences in fasting ghrelin. Greater decreases in CCK from Baseline to Years 1 and 2 were associated with decreases in lack of interest severity at Years 1 and 2, whereas greater increases in ghrelin from Baseline to Years 1 and 2 were associated with decreases in ARFID severity at Years 1 and 2.

Conclusion: In the first longitudinal study of neuroendocrine abnormalities in individuals with ARFID, we found that decreases in CCK and increases in ghrelin were associated with improvements in ARFID symptomology.

J Clin Psychiatry 2026;87(2):25m16046

Author affiliations are listed at the end of this article.

Members Only Content

This full article is available exclusively to Professional tier members. Subscribe now to unlock the HTML version and gain unlimited access to our entire library plus all PDFs. If you're already a subscriber, please log in below to continue reading.

Subscribe Now

Already a member? Log in

  1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Fifth Edition-Text Revision. American Psychiatric Association; 2022.
  2. Sanchez-Cerezo J, Nagularaj L, Gledhill J, et al. What do we know about the epidemiology of avoidant/restrictive food intake disorder in children and adolescents? A systematic review of the literature. Eur Eat Disord Rev. 2023;31(2):226–246. PubMed CrossRef
  3. Thomas JJ, Lawson EA, Micali N, et al. Avoidant/restrictive food intake disorder: a three-dimensional model of neurobiology with implications for etiology and Curr Psychiatry Rep. 2017;19(8):54. PubMed CrossRef
  4. Thomas JJ, Becker KR, Breithaupt L, et al. Cognitive-behavioral therapy for adults with avoidant/restrictive food intake disorder. J Behav Cognitive Ther. 2021;31(1):47–55. PubMed CrossRef
  5. Zickgraf HF, Lane-Loney S, Essayli JH, et al. Further support for diagnostically meaningful ARFID symptom presentations in an adolescent medicine partial hospitalization program. Int J Eat Disord. 2019;52(4):402–409. PubMed CrossRef
  6. Kambanis PE, Tabri N, McPherson I, et al. Prospective 2-year course and predictors of outcome in avoidant/restrictive food intake disorder. J Am Acad Child Adolesc Psychiatry. 2025;64(2):262–275. PubMed CrossRef
  7. Aulinas A, Marengi DA, Galbiati F, et al. Medical comorbidities and endocrine dysfunction in low-weight females with avoidant/restrictive food intake disorder compared to anorexia nervosa and healthy controls. Int J Eat Disord. 2020;53(4):631–636. PubMed CrossRef
  8. Aulinas A, Muhammed M, Becker KR, et al. Oxytocin response to food intake in avoidant/restrictive food intake disorder. Eur J Endocrinol. 2023;189(2):149–155. PubMed CrossRef
  9. Becker KR, Mancuso C, Dreier MJ, et al. Ghrelin and PYY in low-weight females with avoidant/restrictive food intake disorder compared to anorexia nervosa and healthy controls. Psychoneuroendocrinology. 2021;129:105243. PubMed CrossRef
  10. Moran TH. Gut peptides in the control of food intake: 30 years of ideas. Physiology Behav. 2004;82(1):175–180. PubMed CrossRef
  11. Cawthon CR, de La Serre CB. The critical role of CCK in the regulation of food intake and diet-induced obesity. Peptides. 2021;138:170492. PubMed CrossRef
  12. Moran TH, Ladenheim EE. Physiological and neural controls of eating. Gastroenterol Clin North Am. 2016;45(4):581–599. PubMed CrossRef
  13. Burton Murray H, Becker KR, Harshman S, et al. Elevated fasting satiety-promoting cholecystokinin (CCK) in avoidant/restrictive food intake disorder compared to healthy controls. J Clin Psychiatry. 2022;83(5):41767. PubMed CrossRef
  14. Cummings DE, Purnell JQ, Frayo RS, et al. A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes. 2001;50(8):1714–1719. PubMed CrossRef
  15. Schorr M, Miller KK. The endocrine manifestations of anorexia nervosa: mechanisms and management. Nat Rev Endocrinol. 2017;13(3):174–186. PubMed CrossRef
  16. Coniglio KA, Becker KR, Tabri N, et al. Factorial integrity and validation of the Eating Pathology Symptoms Inventory (EPSI). Eat Behav. 2018;31:1–7. PubMed CrossRef
  17. Sysko R, Glasofer DR, Hildebrandt T, et al. The Eating Disorder Assessment for DSM-5 (EDA-5): development and validation of a structured interview for feeding and eating disorders. Int J Eat Disord. 2015;48(5):452–463. PubMed CrossRef
  18. Kaufman J, Birmaher B, Axelson D, et al. Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL, DSM-5). Western Psychiatric Institute and Yale University; 2013.
  19. Bryant-Waugh R, Micali N, Cooke L, et al. Development of the Pica, ARFID, and Rumination Disorder Interview, a multi-informant, semi-structured interview of feeding disorders across the lifespan: a pilot study for ages 10 to 22. Int J Eat Disord. 2019;52(4):378–387. PubMed CrossRef
  20. Fairburn CG, Beglin SJ. Eating Disorder Examination Questionnaire (6.0). In: Fairburn CG, editor. In: Cognitive Behavior Therapy and Eating Disorders. Guilford Press; 2008:309–313.
  21. Cooper-Vince CE, Nwaka C, Eddy KT, et al. The factor structure and validity of a diagnostic interview for avoidant/restrictive food intake disorder in a sample of children, adolescents, and young adults. Int J Eat Disord. 2022;55(11):1575–1588. PubMed CrossRef
  22. Klok MD, Jakobsdottir S, Drent ML. The role of leptin and ghrelin in the regulation of food intake and body weight in humans: a review. Obes Rev. 2007;8(1):21–34. PubMed CrossRef
  23. Moran TH. Cholecystokinin and satiety: current perspectives. Nutrition. 2000;16(10):858–865. PubMed CrossRef
  24. Asakawa A, Inui A, Kaga T, et al. Antagonism of ghrelin receptor reduces food intake and body weight gain in mice. Gut. 2003;52(7):947–952. PubMed CrossRef
  25. Su J, Geng J, Bao J, et al. Two ghrelin receptor agonists for adults with malnutrition: a systematic review and meta-analysis. Nutr J. 2016;15(1):97. PubMed CrossRef
  26. Archibald T, Bryant-Waugh R. Current evidence for avoidant restrictive food intake disorder: implications for clinical practice and future directions. JCPP Adv. 2023;3(2):e12160. PubMed CrossRef
  27. Breton É, Juster R, Booij L. Gender and sex in eating disorders: a narrative review of the current state of knowledge, research gaps, and recommendations. Brain Behav. 2023;13(4):e2871. PubMed CrossRef
  28. Brigham KS, Manzo LD, Eddy KT, et al. Evaluation and treatment of avoidant/restrictive food intake disorder (ARFID) in adolescents. Curr Pediatr Rep. 2018;6(2):107–113. PubMed CrossRef
  29. Thomas JJ, Becker KR, Kuhnle MC, et al. Cognitive-behavioral therapy for avoidant/restrictive food intake disorder (CBT-AR): feasibility, acceptability, and proof-of-concept for children and adolescents. Int J Eat Disord. 2020;53(10):1636–1646. PubMed CrossRef
Buy PDF for $40

Please sign in or purchase this PDF for $40.